SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs - Quaterly Results

05 Feb 2025 Evaluate
The sales figure stood at Rs. 4709.47 millions for the December 2024 quarter. The mentioned figure indicates a growth of about 26.25% as compared to Rs. 3730.31 millions during the year-ago period.The Profit  for the quarter ended December 2024 of  Rs. 735.23  millions  grew by 52.56% from Rs. 481.94 millions.Operating profit surged to 1269.26 millions from the corresponding previous quarter of 887.38 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 4709.47 3730.31 26.25 12417.27 10873.18 14.20 15021.30 15112.50 -0.60
Other Income 119.36 4.64 2472.41 169.96 53.23 219.29 110.10 12.80 760.16
PBIDT 1269.26 887.38 43.03 3004.14 2441.39 23.05 3571.60 3096.20 15.35
Interest 97.03 43.58 122.65 193.45 122.08 58.46 166.30 204.90 -18.84
PBDT 1172.23 843.80 38.92 2810.69 2319.31 21.19 3405.30 2891.30 17.78
Depreciation 210.43 169.36 24.25 582.29 486.89 19.59 660.10 557.70 18.36
PBT 961.80 674.44 42.61 2228.40 1832.42 21.61 2745.20 2333.60 17.64
TAX 226.57 192.50 17.70 543.36 456.10 19.13 738.70 616.30 19.86
Deferred Tax 51.48 62.50 -17.63 124.66 112.50 10.81 278.10 95.00 192.74
PAT 735.23 481.94 52.56 1685.04 1376.32 22.43 2006.50 1717.30 16.84
Equity 453.13 453.13 0.00 453.13 453.13 0.00 453.10 453.10 0.00
PBIDTM(%) 26.95 23.79 13.30 24.19 22.45 7.75 23.78 20.49 16.05

Aarti Pharmalabs Share Price

693.75 4.75 (0.69%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×